Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3200-3206

  Giovarelli, Mirella ^a   Cappello, Paola ^a   Forni, Guido ^a   Salcedo, Theodora ^b   Moore, Paul A ^b   LeFleur, David W ^b   Nardelli, Bernadetta ^b   Di Carlo, Emma ^c   Lollini, Pier Luigi ^d   Ruben, Steve ^b   Ullrich, Stephen ^b   Garotta, Gianni ^b,e   Musiani, Piero ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Serono International SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; LYMPHOCYTE MIGRATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; TUMOR REJECTION;

EID: 0034653473     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3200     Document Type: Article

References (29)

1. Wang, J. M., X. Deng, W. Gong, and S. Su. 1998. Chemokines and their role in tumor growth and metastases, J. Immunol. Methods 200:1.
2. Naruse, K., M. Ueno, T. Satoh, H. Nomiyama, H. Tei, M. Takeda, D. H. Ledbetter, E. V. Coillie, G. Opdenakker, N. Gunge, et al. 1996. A YAC contig of the human CC chemokine genes clustered on chromosome 17q11.2. Genomics 34:236.
3. Fukuda, S., Y. Hanano, M. Iio, R. Miura, O. Yoshie, and H. Nomiyama. 1999. Genomic organization of the genes for human and mouse CC chemokine LEC. DNA Cell Biol. 18:275.
4. Shoudai, K., K. Hieshima, S. Fukuda, M. Iio, R. Miura, T. Imai, O. Yoshie, and H. Nomiyama. 1998. Isolation of cDNA encoding a novel human CC chemokine NCC-4/LEC. Biochim. Biophys. Acta 1396:273.
5. Hedrick, J. A., A. Helms, A. Vicari, and A. Zlotnik. 1998. Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10. Blood 91:4242.
6. Youn, B. S., S. Zhang, H. E. Broxmeyer, K. Antol, M. J. Fraser, Jr., G. Hangoc, and B. S. Kwon. 1998. Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine, with myelosuppressive activity. Biochem. Biophys. Res. Commun. 247:217.
7. Nardelli, B., T. W. Salcedo, D. K. Morahan, E. V. Cochrane, M. Giovarelli, and G. Forni. 1999. Functional characterization of the CC chemokine Ckβ12/HCC-4/LEC. FASEB J. 13:A317 (Abstr.).
8. Musiani, P., A. Modesti, M. Giovarelli, F. Cavallo, M. P. Colombo, P. L. Lollini, and G. Forni. 1997. Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol. Today 18:32.
9. Cavallo F., P. Signorelli, M. Giovarelli, P. Musiani, A. Modesti, M. J. Brunda, M. P. Colombo, and G. Forni. 1997. Antitumor efficacy of adenocarcinoma cells engineered to produce inlerleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J. Natl. Cancer Inst. 89:1049.
10. Giovarelli, M., and P. Cappello. 1998. TS/A Mammary Adenocarcinoma: a prevalent international standard for studies in tumor immunology. Immunol. Blackboard (http://pages.inrete it/immunoblack) 3:5.
11. Giovarelli, M., A. Santoni, and G. Forni. 1985. Alloantigen-activated lymphocytes from mice bearing a spontaneous "non-immunogenic" adenocarcinoma inhibit its growth by recruiting host immunoreactivity. J. Immunol. 133:3596.
12. Di Carlo, E., A. Coletti, A. Modesti, M. Giovarelli, G. Forni, and P. Musiani. 1998. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. Eur. Cytokine Network 9:61.
13. + lymphocyte driven and eosinophil mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release 1L-4. J. Immunol. 153:5659.
14. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol. 149:3627.
15. Sozzani, S. P. Allavena, G. D'Amico, W. Luini, G. Bianchi, M. Kataura, T. Imai T, O. Yoshie, R. Bonecchi, and A. Mantovani. 1998. Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 161:1083.
16. Adema, G. F., F. Hangers, R. Verstraten., E. De Vries, G. Marland., S. Menon., J. Foster, Y. Xu, P. Nooyen, T. McClanahan, et al. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387:713.
17. Sallusto, F., P. Schaerli, P. Loetscher, C. Schaniel, D. Lenig, C. R. Mackay. S. Qin., and A. Lanzavecchia. 1998. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 298:2760.
18. Mantovani, A. 1999. The chemokine system: redundancy for robust outputs. Immunol. Today 20:254.
19. Grabbe, S., S. Beissert, T. Schwarz, and R. D. Granstein. 1995. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today 16:117.
20. Zitvogel, L., J. L. Mayordomo, T. Tjandrawan, A. B. DeLeo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87.
21. Musiani, P., A. Allione, A. Modica, P. L. Lollini, M. Giovarelli., F. Cavallo., F. Belardelli, G. Forni, and A. Modesti. 1996. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-α, IFN-γ, and TNF-α. Lab. Invest. 74:146.
22. Colombo, M. P., A. Modesti, G. Parmiani, and G. Forni. 1992. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res. 52:4583.
23. Chiodoni, C., P. Paglia, A. Stoppacciaro, M. Rodolfo, M. Parenza, and M. P. Colombo. 1999. Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J. Exp. Med 190:124.
24. Forni, G., H. Fujiwara, F. Martino, T. Hamaoka, C. Jemma, P. Caretto, and M. Giovarelli. 1988. Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy. Cancer Metastasis Rev. 7:289.
25. Forni, G., and M. Giovarelli. 1984. In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo. J. Immunol. 132:527.
26. + T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ. Proc. Natl. Acad. Sci. USA 96:8633.
27. Giovarelli, M., P. Musiani, A. Modesti, P. Dellabona, G. Casorati, A. Allione, M. Consalvo, F. Cavallo, F. Di Pierro, C. De Giovanni, et al. 1995. The local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances the antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody dependent immune memory. J. Immunol. 155:3112.
28. Melcher, A., S. Todryk, N. Hardwick, M. Ford, M. Jacobson, and R. G. Vile. 1998, Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4:581.
29. Allione, A., M. Consalvo, P. Nanni, P. L. Lollini, F. Cavallo, M. Giovarelli, M. Forni, A. Gulino, M. P. Colombo, P. Dellabona, et al. 1994. Immunizing and curative potential of replicating and non-replicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor a, granulocyte-macrophage colony-stimulating factor, and γ-interferon gene or admixed with conventional adjuvants. Cancer Res. 54:6022.